MENU
ARQT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Arcutis Biotherapeutics (ARQT) Ownership - Who owns Arcutis Biotherapeutics?
Profile
Industry
N/A
Address
3027 Townsgate Road
Phone
+1 805 418-5006
Employees
296
Web
https://www.arcutis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.16B
P/E Ratio
N/A
Total Cash
362.44M
Projected Growth
N/A
Total Debt
207.56M
Revenue
132.06M
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash/Share
3.10
Total Debt/Equity
N/A
Revenue/Share
1.19 USD as % of share price
Fundamentals
ARQT
Capitalization
1.16B
P/E Ratio
N/A
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash
362M
Total Cash/Share
3.10
Total Debt
208M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.19%
Revenue
132M
ROE
N/A
Book Value
186M
P/B Ratio
7.77
Cash Flow
N/A
Earnings
-2.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
8.46
Current Revenue Per Employee
104250.00
Dividends Per Share - Security
N/A
EBITDA
-163.56M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.77
Revenue To Assets
-51.93
Shares Held By Institutions
1.58B
Shares Outstanding - Current
117M
Total Liabilities
258M
Total Volume MTD
N/A
Value
N/A
Gain YTD
221.981
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the development and commercialization of treatments for dermatological diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3027 Townsgate Road
Phone
+1 805 418-5006
Employees
296
Web
https://www.arcutis.com